| 刘飞 贾鑑慧 孙丽萍 祝沈冬 段宏燕 段晨阳.奥利沙铂、多西紫杉醇化疗方案联合同步三维适形放疗治疗晚期非小细
胞癌的近期临床疗效观察[J].现代生物医学进展英文版,2014,14(7):1315-1319. |
| 奥利沙铂、多西紫杉醇化疗方案联合同步三维适形放疗治疗晚期非小细
胞癌的近期临床疗效观察 |
| Clinical Observation on Oxaliplatin Plus Docitaxel Combined withConcurrent Three Dimensional Conformal Radiotherapy in Treatment ofPatients with Limited Advanced Non-small Cell Lung Cancer |
| |
| DOI： |
| 中文关键词: 三维适形放疗 奥利沙铂 多西紫杉醇 疗效 生活质量 毒副反应 |
| 英文关键词: Three dimensional conformal radiotherapy Oxaliplatin Docitaxel Clinical efficacy Life quality Toxicity |
| 基金项目:国家自然科学基金项目(30872464) |
|
| Hits: 750 |
| Download times: 1103 |
| 中文摘要: |
| 目的：观察并探讨奥利沙铂（Oxaliplatin,L-OHP）与多西紫杉醇（Docetaxel,DXL）化疗方案联合同步三维适形放疗（three
dimensional conformal radiotherapy,3DCRT）治疗晚期局限性非小细胞肺癌(non-small cell lung cancer, NSCLC)的近期临床效果并
安全性。方法：将2010 年1 月-2012 年2 月间入选的94 例局限性NSCLC 患者随机单盲分为观察组（48 例）与对照组（46 例）,观
察组给予L-OHP、DXL 化疗方案并联合同步3DCRT 治疗方案，对照组予3DCRT 治疗方案，对比两组治疗后临床疗效、生命质量
改善情况及治疗期间毒副反应。结果：①两组患者疗效构成不同，观察组完全缓解率（12.5%）与总有效率（81.3%）均高于对照组
（6.5%、58.7%），且后者差异具有统计学意义（X2=5.713, P=0.017）；②观察组、对照组治疗后生活质量改善比例分别为56.6%、
33.3%，两组生活质量具有显著性差异（Z= -2.101, P=0.036）；③治疗期间观察组、对照组分别死亡2 例（4.2%）、1 例（2.2%），观察组
骨髓抑制、胃肠道反应、末梢神经损害、放射性肺损伤发生率高于对照组（P＜ 0.05）。结论：L-OHP 与DXL 化疗联合同步3DCRT
放疗治疗NSCLC 可提高后者对原发病灶的近期控制率、改善患者生活质量，但也应注意对联合放化疗期间出现毒副反应的对症
处置。 |
| 英文摘要: |
| Objective:The The paper is to observe on recent clinical efficacy and toxicity reaction of Oxaliplatin (L-OHP) plus
Docitaxel (DXL)combined with concurrent three dimensional conformal radiotherapy(3DCRT) in treatment of patients with limited advanced
non-small cell lung cancer (NSCLC).Methods:Prospective study was conducted on 94 admitted NSCLS patients fromJan. 2010 to
Feb.2012, and 94 cases were randomized into observation (n=48) & control group (n=46), observation group was applied with L-OHP
plus DXL combined concurrent 3DCRT scheme, and control group was only treated with 3DCRT regime, during and after which clinical
efficacy, quality of life improvement,toxic &side reactions were compared between 2 groups. Results:①2 groups with different clinical
efficacy, complete remission rate & total efficiency rate of observation group were higher than those of control group (12.5%VS.6.5%,
81.3%VS.58.7%), and the difference of total efficacy rate was statistically significant (X2=5.713, P=0.017).②Quality of life with obvious
improvement of observation &control group were 56.6%, 33.3%respectively, and there was significant difference ( Z= -2.101, P=0.036
).③During treatment, Observational group had seen 2(4.2%) death cases, while control group with 1( 2.2%), death case during treatment,
incidence rate of myelosuppression, gastrointestinal tract reaction, peripheral nerve damage, radiation induced lung injury in observation
group was higher than that of control group ( P < 0.05 ).Conclusion:L-OHP plus DXL chemotherapy combined with concurrent 3DCRT
radiotherapy in treatment of limited advanced NSCLC can improve recent control rate of primary lesion, and also enhance patients' life
quality, but attention also should be paid to strengthening symptomatic disposal for reactions occured during combination of radio-chemo
therapy . |
|
View Full Text
View/Add Comment Download reader |
| Close |
|
|
|
